IP Library Granted Patent US 8,946,262
Granted Patent B2
US 8,946,262 · App. 10/999,054 · Granted Feb 3, 2015

Methods of preventing and treating gastrointestinal dysfunction

Inventors: David D Christ (Newark, DE); Bruce A Wallin (Haverford, PA); Deanne D Garver (Downingtown, PA); William K Schmidt (Davis, CA); David Jackson (Cape Coral, FL)
Assignee: Adolor Corporation
A61K31/445
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,946,262
App. No.
10/999,054
Granted
Feb 3, 2015
Kind
B2
Abstract

Methods of preventing and treating gastrointestinal dysfunction, particularly postoperative ileus and post-partum ileus, in a patient undergoing surgery or other biological stress by administering 4-aryl-piperidine derivatives are disclosed.

Claims (7)

1. A method of treating a gastrointestinal dysfunction in a patient undergoing surgery, comprising the step of:

orally administering to the patient from about 30 minutes prior to surgery to 60 minutes prior to surgery about 12 mg of a compound which is [[2-[[-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid or a pharmaceutically acceptable salt or hydrate thereof.

2. A method according to claim 1 , wherein said compound is 2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenyl-propanoyl]amino]acetic acid dihydrate.

3. A method according to claim 2 , wherein the surgery is abdominal surgery.

4. A method of claim 3 , wherein the gastrointestinal dysfunction is postoperative ileus.

5. A method of claim 2 , wherein the compound is administered to the patient from about 30 minutes prior to surgery to less than 60 minutes prior to surgery.

6. A method of claim 2 , wherein the compound is administered to the patient from about 30 minutes prior to surgery to less than 45 minutes prior to surgery.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: CALIXA THERAPEUTICS, INC.; ADOLOR CORPORATION; CUBIST PHARMACEUTICALS, INC.
Reel/Frame 036180/0070 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 9, 2015
From: ADOLOR CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036046/0153 →
SECURITY AGREEMENT Recorded Nov 20, 2012
From: CUBIST PHARMACEUTICALS, INC.; ADOLOR CORPORATION; CALIXA THERAPEUTICS, INC.; CUBIST PHARMACEUTICALS HOLDINGS, INC.; CUBIST PHARMACEUTICALS U.S.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 029339/0669 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2005
From: CHRIST, DAVID D.; WALLIN, BRUCE A.; GARVER, DEANNE D.; SCHMIDT, WILLIAM K.; JACKSON, DAVID
To: ADOLOR CORPORATION
Reel/Frame 015647/0152 →
Continuity (2)
Provisional Application 60526851 · Dec 4, 2003
Related Publication 20050124657A1 · Jun 9, 2005